BNP Paribas Maintains Neutral on Clorox, Lowers Price Target to $95

Benzinga Newsdesk www.benzinga.com Negative 61.6%

Neg 61.6% Neu 0% Pos 0%

BNP Paribas analyst Kevin Grundy maintains Clorox (NYSE:CLX) with a Neutral and lowers the price target from $97 to $95.